Blood Advances (Oct 2019)

CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia

  • Joshua N. Gustine,
  • Lian Xu,
  • Nicholas Tsakmaklis,
  • Maria G. Demos,
  • Amanda Kofides,
  • Jiaji G. Chen,
  • Xia Liu,
  • Manit Munshi,
  • Maria Luisa Guerrera,
  • Gloria G. Chan,
  • Christopher J. Patterson,
  • Andrew Keezer,
  • Kirsten Meid,
  • Toni Dubeau,
  • Guang Yang,
  • Zachary R. Hunter,
  • Steven P. Treon,
  • Jorge J. Castillo

Journal volume & issue
Vol. 3, no. 19
pp. 2800 – 2803

Abstract

Read online

No abstracts available.